Answers are grounded in this paper and cite their sources.
assays revealed high diastereoselectivity, as well as a substrate tolerance by the terminal adenylation domain of the non-ribosomal peptide synthetase (NRPS) SulM toward the majority of synthetic analogs. Chemical complementation of this mutant yielded a fluorinated, bioactive monobactam through fermentation as confirmed by a combination of spectrometric data and microbiological assays. This study demonstrates site-specific functionalization of a clinically important natural product and sets in place a platform for further strain improvements and engineered NRPS-biosynthesis of non-native congeners.
No takes yet. Share an insight, caveat, or question.
Lichstrahl et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: